September 4, 2025 · Form 4 insider transaction
Tessari Eben bought 38,725 shares of Kiniksa Pharmaceuticals Ltd. at $15.50 per share, a transaction worth $600.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 29, 2024.